SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS FLASH M impact

Pfizer Raises 2026 Forecasts After Q3 Beat

Pfizer said Eliquis and cancer drugs drove its third-quarter beat and raised its 2026 forecasts.

PFE
SquawkNews Desk 1 updates Updated Nov 03, 2026, 12:29 PM UTC

Story updates

12:29:35 PM UTC
SquawkNews
NEW YORK CITY (dpa-AFX) - While reporting financial results for the third quarter on Tuesday, drug major Pfizer, Inc. (PFE) raised its adjusted earnings and revenue guidance for the full-year 2026, reflecting strong year-to-date performance and confidence in business.For fiscal 2026, the company co…

Related stories

BMW Cuts Automotive Outlook for Second Time BMW cut its automotive outlook for a second time as restructuring deepens. M impact | EARNINGS | Nov 03, 2026, 07:33 PM UTC Pinnacle West Capital Shares Rise After Q3 Beat L impact | EARNINGS | Nov 03, 2026, 07:32 PM UTC Columbus McKinnon Raises Fiscal 2027 Guidance; Shares Rise More Than 15% Columbus McKinnon raised its fiscal 2027 guidance, and its shares were up more than 15%. M impact | EARNINGS | Nov 03, 2026, 07:30 PM UTC Dana Raises 2026 Sales Guidance to About $7.8 Billion Dana raised its sales forecast for 2026 to about $7.8 billion. M impact | EARNINGS | Nov 03, 2026, 07:24 PM UTC Weng Fine Art Cuts 2025 Net Profit to About EUR 4.7 Million Weng Fine Art cut its 2025 net profit forecast to about EUR 4.7 million after accounting corrections. M impact | EARNINGS | Nov 03, 2026, 07:10 PM UTC Deckers Raises Fiscal 2027 EPS Guidance to $7.80-$7.95 Deckers said international sales rose 9% year over year to $644.7 million, while consolidated revenue grew 3.5%. The revised EPS outlook includes about 52 cents per share from IEEP M impact | EARNINGS | Nov 03, 2026, 07:03 PM UTC